• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一个具有基因组不稳定性的透明细胞肾细胞癌的 lncRNA 特征的计算预后模型。

A computational prognostic model of lncRNA signature for clear cell renal cell carcinoma with genome instability.

机构信息

Department of Ultrasound, China-Japan Union Hospital of Jilin University, Changchun, Jilin Province, China.

Department of Cardiac Surgery, The First Hospital of Jilin University, Changchun, Jilin Province, China.

出版信息

Expert Rev Mol Diagn. 2022 Feb;22(2):213-222. doi: 10.1080/14737159.2021.1979960. Epub 2021 Dec 6.

DOI:10.1080/14737159.2021.1979960
PMID:34871123
Abstract

Long non-coding RNAs (lncRNAs) play a critical role in genomic instability and prognosis of cancer patients, but the methods to identify genomic instability-related lncRNAs have yet to be established. In the present study, to assess the prognostic value of lncRNAs associated with genomic instability in clear cell renal cell carcinoma (ccRCC).A computational framework was established based on the mutation hypothesis and combined lncRNA expression and somatic mutation profiles of the ccRCC genome. Furthermore, a prognostic model was developed using the genome instability-derived lncRNA signature GILncSig based on three lncRNA genes (LINC02471, LINC01234, and LINC00460) and verified using multiple independent patient cohorts.This study established an effective computational method to study the role of lncRNAs in genomic instability, with potential applications in identifying new genomic instability-related cancer biomarkers.

摘要

长链非编码 RNA(lncRNA)在基因组不稳定性和癌症患者预后中发挥着关键作用,但鉴定与基因组不稳定性相关的 lncRNA 的方法尚未建立。本研究旨在评估与透明细胞肾细胞癌(ccRCC)中基因组不稳定性相关的 lncRNA 的预后价值。

本研究基于突变假说,结合 ccRCC 基因组的 lncRNA 表达和体细胞突变谱,建立了一个计算框架。此外,还基于三个 lncRNA 基因(LINC02471、LINC01234 和 LINC00460)的基因组不稳定性衍生 lncRNA 特征 GILncSig 开发了一个预后模型,并使用多个独立的患者队列进行了验证。

本研究建立了一种有效的计算方法来研究 lncRNA 在基因组不稳定性中的作用,具有识别新的与基因组不稳定性相关的癌症生物标志物的潜在应用。

相似文献

1
A computational prognostic model of lncRNA signature for clear cell renal cell carcinoma with genome instability.一个具有基因组不稳定性的透明细胞肾细胞癌的 lncRNA 特征的计算预后模型。
Expert Rev Mol Diagn. 2022 Feb;22(2):213-222. doi: 10.1080/14737159.2021.1979960. Epub 2021 Dec 6.
2
Genome instability-related long non-coding RNA in clear renal cell carcinoma determined using computational biology.基于计算生物学的 clear 肾细胞癌中与基因组不稳定性相关的长链非编码 RNA
BMC Cancer. 2021 Jun 24;21(1):727. doi: 10.1186/s12885-021-08356-9.
3
Prediction of bladder cancer outcome by identifying and validating a mutation-derived genomic instability-associated long noncoding RNA (lncRNA) signature.通过鉴定和验证与基因突变相关的基因组不稳定性的长链非编码 RNA(lncRNA)特征来预测膀胱癌的预后。
Bioengineered. 2021 Dec;12(1):1725-1738. doi: 10.1080/21655979.2021.1924555.
4
Establishing a Prognostic Model Based on Three Genomic Instability-related LncRNAs for Clear Cell Renal Cell Cancer.基于三个与基因组不稳定性相关的长非编码 RNA 建立透明细胞肾细胞癌的预后模型。
Clin Genitourin Cancer. 2022 Aug;20(4):e317-e329. doi: 10.1016/j.clgc.2022.02.005. Epub 2022 Feb 24.
5
Genome-wide screening and cohorts validation identifying novel lncRNAs as prognostic biomarkers for clear cell renal cell carcinoma.全基因组筛选和队列验证鉴定新型 lncRNAs 作为透明细胞肾细胞癌的预后生物标志物。
J Cell Biochem. 2020 Mar;121(3):2559-2570. doi: 10.1002/jcb.29478. Epub 2019 Oct 23.
6
A Novel Tumor Mutation Burden Related lncRNA Signature Identified Prognosis and Tumor Immune Microenvironment Features in Clear Cell Renal Cell Carcinoma.一种新型肿瘤突变负担相关 lncRNA 标志物鉴定出透明细胞肾细胞癌的预后和肿瘤免疫微环境特征。
Comb Chem High Throughput Screen. 2023;26(8):1503-1518. doi: 10.2174/1386207325666220926123923.
7
Identification and validation of a novel eight mutant-derived long non-coding RNAs signature as a prognostic biomarker for genome instability in low-grade glioma.鉴定和验证一种新型的八个突变衍生的长非编码 RNA 特征作为低级别胶质瘤基因组不稳定性的预后生物标志物。
Aging (Albany NY). 2021 Jun 3;13(11):15164-15192. doi: 10.18632/aging.203079.
8
Construction of a genome instability-derived lncRNA-based risk scoring system for the prognosis of hepatocellular carcinoma.构建基于基因组不稳定性的 lncRNA 风险评分系统用于预测肝细胞癌的预后。
Aging (Albany NY). 2021 Nov 18;13(22):24621-24639. doi: 10.18632/aging.203698.
9
Identification of a glycolysis-related lncRNA prognostic signature for clear cell renal cell carcinoma.鉴定透明细胞肾细胞癌中与糖酵解相关的 lncRNA 预后特征。
Biosci Rep. 2021 Aug 27;41(8). doi: 10.1042/BSR20211451.
10
Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data.基于六个长链非编码 RNA 风险评分的透明细胞肾细胞癌 (ccRCC) 预后:基于 RNA 测序数据的研究。
J Transl Med. 2019 Aug 23;17(1):281. doi: 10.1186/s12967-019-2032-y.

引用本文的文献

1
Identification of ATP6V0A4 as a potential biomarker in renal cell carcinoma using integrated bioinformatics analysis.通过综合生物信息学分析鉴定ATP6V0A4作为肾细胞癌的潜在生物标志物
Oncol Lett. 2023 Jul 11;26(3):366. doi: 10.3892/ol.2023.13952. eCollection 2023 Sep.
2
Comprehensive analysis of the prognosis and immune infiltration of TMC family members in renal clear cell carcinoma.全面分析 TMC 家族成员在肾透明细胞癌中的预后和免疫浸润情况。
Sci Rep. 2023 Jul 19;13(1):11668. doi: 10.1038/s41598-023-38914-z.
3
Construction of a prognostic model for HCC based on ferroptosis-related lncRNAs expression and its potential to predict the response and irAEs of immunotherapy.
基于铁死亡相关长链非编码RNA表达构建肝癌预后模型及其预测免疫治疗反应和免疫相关不良反应的潜力。
Front Pharmacol. 2023 Mar 13;14:1090895. doi: 10.3389/fphar.2023.1090895. eCollection 2023.
4
Prediction of the Prognosis of Clear Cell Renal Cell Carcinoma by Cuproptosis-Related lncRNA Signals Based on Machine Learning and Construction of ceRNA Network.基于机器学习的铜死亡相关lncRNA信号预测透明细胞肾细胞癌预后及ceRNA网络构建
J Oncol. 2023 Mar 13;2023:4643792. doi: 10.1155/2023/4643792. eCollection 2023.
5
Identification of an immunogenic cell death-related gene signature predicts survival and sensitivity to immunotherapy in clear cell renal carcinoma.鉴定免疫原性细胞死亡相关基因特征可预测透明细胞肾细胞癌的生存和免疫治疗敏感性。
Sci Rep. 2023 Mar 17;13(1):4449. doi: 10.1038/s41598-023-31493-z.
6
Establishment and validation of a clinicopathological prognosis model of gastroenteropancreatic neuroendocrine carcinomas.胃肠胰神经内分泌癌临床病理预后模型的建立与验证
Front Oncol. 2022 Sep 26;12:999012. doi: 10.3389/fonc.2022.999012. eCollection 2022.
7
Identification of a combined lncRNA prognostic signature and knockdown of lncRNA MANCR to inhibit progression of clear cell renal cell carcinoma by bioinformatics analysis.通过生物信息学分析鉴定lncRNA联合预后特征并敲低lncRNA MANCR以抑制透明细胞肾细胞癌进展
Transl Androl Urol. 2022 Sep;11(9):1304-1317. doi: 10.21037/tau-22-527.